Advertisement

Topics

Danish biotech Zealand Pharma nets $72.7mm in U.S. IPO

15:40 EDT 11 Aug 2017 | Elsevier Business Intelligence

Zealand Pharma AS (peptide-based medicines focused on metabolic and gastrointestinal diseases) netted $72.7mm in its US initi...

Original Article: Danish biotech Zealand Pharma nets $72.7mm in U.S. IPO

NEXT ARTICLE

More From BioPortfolio on "Danish biotech Zealand Pharma nets $72.7mm in U.S. IPO"

Quick Search
Advertisement